日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Superior outcomes with the FABT regimen in haploidentical transplantation for aplastic anemia in patients under 40 years old: a single-center retrospective study

FABT方案在40岁以下再生障碍性贫血患者的单倍体相合移植中显示出更优的疗效：一项单中心回顾性研究

期刊:Clinical and Experimental Medicine
影响因子:3.5
doi:10.1007/s10238-026-02105-7
Tan, Zhengwei; Zhu, Ningning; Zhao, Yuechao; Hu, Huijin; Yu, Qinghong; Zhang, Yu; Hu, Tonglin; Wu, Dijiong; Ye, Baodong; Liu, Wenbin
贫血
代谢
发表日期：2026
文献求助 收藏

Matrine enhances RLS3-induced ferroptosis at non-toxic doses in acute myeloid leukemia cells with MLL rearrangement

在具有 MLL 重排的急性髓系白血病细胞中，苦参碱在非毒性剂量下可增强 RLS3 诱导的铁死亡。

期刊:American Journal of Cancer Research
影响因子:2.9
doi:10.62347/YKIG8290
Hong, Yaonan; Li, Man; Yu, Fanhua; Wu, Shiyue; He, Shun; Yang, Xiawan; Wang, Peicheng; Liu, Qi; Shen, Yingying; Kai, Guoyin; Ye, Baodong; Shao, Keding; Wu, Dijiong
白血病
细胞生物学
毒理研究
铁死亡
发表日期：2026
文献求助 收藏

Luspatercept for the treatment of transfusion-dependent non-severe aplastic anemia

Luspatercept 用于治疗输血依赖型非重型再生障碍性贫血

期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-026-06785-9
Jia, Xinru; Zheng, Rudan; Hong, Yaonan; Ge, Hangping; Shen, Yingying; Zhou, Yuhong; Yang, Xiawan; Wu, Dijiong
贫血
代谢
发表日期：2026
文献求助 收藏

Plasma exchange combined with anti-B-cell therapy enables comparable outcomes between DSA-positive and DSA-negative aplastic anemia after haplo-HSCT: a propensity-score-matched cohort study

血浆置换联合抗B细胞疗法可使单倍体造血干细胞移植后DSA阳性和DSA阴性再生障碍性贫血患者的疗效相当：一项倾向评分匹配队列研究

期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-026-06815-6
Tan, Zhengwei; Hu, Jinyu; Zhao, Yuechao; Hu, Huijin; Yu, Qinghong; Zhang, Yu; Wu, Liqiang; Hu, Tonglin; Wu, Dijiong; Ye, Baodong; Liu, Wenbin
B细胞
发育与干细胞
代谢
干细胞
细胞生物学
贫血
免疫/内分泌
发表日期：2026
文献求助 收藏

Comparison of clinical outcomes between early and delayed allogeneic hematopoietic stem cell transplantation for severe aplastic anemia: a single-center retrospective study

比较早期和延迟异基因造血干细胞移植治疗重型再生障碍性贫血的临床疗效：一项单中心回顾性研究

期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-026-06869-6
Tan, Zhengwei; Zhao, Yuechao; Hu, Huijin; Yu, Qinghong; Zhang, Yu; Hu, Tonglin; Wu, Dijiong; Ye, Baodong; Liu, Wenbin
发育与干细胞
代谢
干细胞
细胞生物学
贫血
发表日期：2026
文献求助 收藏

Cord blood transfusion added matched unrelated donor transplantation as a preferable choice for aplastic anaemia: a comparative study from a single centre

脐带血输注联合非亲缘供者移植是治疗再生障碍性贫血的更佳选择：一项来自单中心的比较研究

期刊:
影响因子:
doi:10.1080/07853890.2026.2635832
Hu, Tonglin; Jia, Xinru; Xin, Chuanao; Shen, Yingying; Liu, Qi; Hong, Yaonan; Liu, Shan; Sun, Zexing; Zheng, Rudan; Yang, Xiawan; Liu, Wenbin; Yu, Qinghong; Shen, Jianping; Lin, Shengyun; Zhou, Yuhong; Ye, Baodong; Wu, Dijiong
贫血
代谢
发表日期：2026
文献求助 收藏

Integrated stress response activation induced by usnic acid alleviates BCL-2 inhibitor ABT-199 resistance in acute myeloid leukemia.

松萝酸诱导的整合应激反应激活可缓解急性髓系白血病中 BCL-2 抑制剂 ABT-199 的耐药性

期刊:Journal of Advanced Research
影响因子:13
doi:10.1016/j.jare.2024.10.003
Wu Dijiong, Li Man, Hong Yaonan, Jin Li, Liu Qi, Sun Chengtao, Li Liqin, Han Xiaoxiao, Deng Shengqian, Feng Yue, Shen Yiping, Kai Guoyin
肿瘤
白血病
肿瘤免疫
发表日期：2025
文献求助 收藏

Current Knowledge of the Integrated Stress Response in the Development and Management of Acute Myeloid Leukemia: A Novel Target with Encouraging Progress

急性髓系白血病发生发展及治疗中整合应激反应的最新认识：一个具有令人鼓舞进展的新靶点

期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S573043
Jiang, Wanzhi; Hong, Yaonan; Wang, Peicheng; Yang, Xiawan; Shao, Keding; Li, Man; Wu, Dijiong
白血病
发表日期：2025
文献求助 收藏

Reduced dose prednisone plus eltrombopag for the treatment of newly diagnosed adult primary immune thrombocytopenia: A prospective, multicentre, phase 2 clinical trial

降低剂量泼尼松联合艾曲波帕治疗新诊断的成人原发性免疫性血小板减少症：一项前瞻性、多中心、II期临床试验

期刊:British Journal of Haematology
影响因子:3.8
doi:10.1111/bjh.70168
Liu, Qi; Dong, Xiaohui; Rong, Chunmeng; Shen, Yingying; Xu, Linglong; Zhou, Mei; Xu, Xiaohua; Cai, Jiaohao; Wu, Liqiang; Chen, Sai; Qiu, Di; Zhao, Jianzhi; Zhou, Penglei; Liu, Shan; Liu, Wenbin; Hu, Huijing; Zhao, Yuechao; Zhang, Yun; Zhou, Yuhong; Shen, Yiping; Ye, Baodong; Xia, Yongming; Shou, Lihong; Wu, Dijiong
血小板
免疫/内分泌
发表日期：2025
文献求助 收藏

Corrigendum to "Gilteritinib overcomes primary resistance to venetoclax in a patient with FLT3 wild-type refractory/relapsed AML: Case report and exploration of possible mechanisms" [Heliyon Volume 10, Issue 16, August 30, 2024, Article e35847]

对“吉瑞替尼克服FLT3野生型难治性/复发性AML患者对维奈托克的原发性耐药：病例报告及可能机制的探索”的更正[Heliyon 第10卷，第16期，2024年8月30日，文章e35847]

期刊:Heliyon
影响因子:3.6
doi:10.1016/j.heliyon.2025.e42725
Li, Man; Yang, Xiawan; Hong, Yaonan; Liu, Qi; Shen, Yingying; Hu, Tonglin; Shen, Yiping; Kai, Guoyin; Wu, Dijiong
FLT3
发表日期：2025
文献求助 收藏